BROMOCRIPTINE (PARLODEL) IN THE TREATMENT OF PARKINSONS-DISEASE

被引：4
|
作者：
MOLINANEGRO, P
GRIMES, JD
JONES, MW
KOFMAN, OS
BOUCHARD, S
机构：
[1] SANDOZ, DEPT MED SERV, MONTREAL, QUEBEC, CANADA
[2] SHAUGHNESSY HOSP, VANCOUVER V6H 3N1, BC, CANADA
[3] OTTAWA CIVIC HOSP, OTTAWA K1Y 4E9, ONTARIO, CANADA
[4] MT SINAI HOSP, TORONTO M5G 1X5, ONTARIO, CANADA
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1982年 / 6卷 / 4-6期
关键词：
D O I：
10.1016/S0278-5846(82)80139-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：503 / 508
页数：6
相关论文
共 50 条
  • [31] NEUROPSYCHIATRIC SIDE-EFFECTS OF BROMOCRIPTINE IN THE TREATMENT OF PARKINSONS-DISEASE
    SIMONETTA, M
    SCHMITT, L
    MONTASTRUC, JL
    RASCOL, A
    REVUE NEUROLOGIQUE, 1987, 143 (8-9) : 608 - 611
  • [32] PHARMACOKINETICS OF BROMOCRIPTINE DURING CONTINUOUS ORAL TREATMENT OF PARKINSONS-DISEASE
    FRIIS, ML
    GRON, U
    LARSEN, NE
    PAKKENBERG, H
    HVIDBERG, EF
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (04) : 275 - 280
  • [33] TREATMENT OF PARKINSONS-DISEASE - PSYCHOTHERAPY IN PARKINSONS-DISEASE
    CHAFETZ, ME
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1956, 123 (02) : 189 - 189
  • [34] THE INFLUENCE OF LEVODOPA IN THE PHARMACOKINETICS OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    RABEY, JM
    OBERMAN, Z
    SCHARF, M
    ISAKOV, A
    BAR, M
    GRAFF, E
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 440 - 447
  • [35] THE INFLUENCE OF BROMOCRIPTINE ON THE PHARMACOKINETICS OF LEVODOPA IN PARKINSONS-DISEASE
    RABEY, JM
    SCHWARTZ, M
    GRAFF, E
    HARSAT, A
    VERED, Y
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (06) : 514 - 522
  • [36] BROMOCRIPTINE IN PARKINSONS-DISEASE - A STUDY OF CARDIOVASCULAR EFFECTS
    QUINN, N
    ILLAS, AC
    LHERMITTE, F
    AGID, Y
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (05): : 426 - 429
  • [37] LOW-DOSE BROMOCRIPTINE IN PARKINSONS-DISEASE
    PEARCE, I
    PEARCE, JMS
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (04): : 388 - 389
  • [38] EFFICACY OF SMALL DOSES OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    MYLLYLA, VV
    SAARINEN, A
    YLOSTALO, P
    HOKKANEN, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 33 (01): : 144 - 149
  • [39] BROMOCRIPTINE IN DE NOVO PARKINSONS-DISEASE PATIENTS
    GAWELL, MJ
    KING, DB
    LIBMAN, I
    MCLEAN, DR
    PAULSETH, R
    RAPHY, B
    RIOPELLE, RJ
    BOUCHARD, S
    ARCHIVES OF NEUROLOGY, 1988, 45 (02) : 206 - 206
  • [40] THE LONGTERM MANAGEMENT OF ADVANCED PARKINSONS-DISEASE WITH BROMOCRIPTINE
    GRIMES, D
    HASSAN, M
    GRAY, P
    MIRELES, R
    KAPOOR, A
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1982, 9 (02) : 287 - 287
12345